Stay updated on Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page. This update appears to be a minor metadata change without altering the reported study details or layout.
    Difference
    0.1%
    Check dated 2026-05-15T15:35:37.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The collaborators list was updated to replace Instituto de Patologia e Imunologia Molecular da Universidade do Porto with Universidade do Porto as a study collaborator.
    Difference
    0.1%
    Check dated 2026-05-01T10:00:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s revision/version indicator is updated from **v3.5.2** to **v3.5.3**, reflecting a minor release of the ClinicalTrials.gov page template/software without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:01.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:27.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The two screenshots show the same study record with identical core content. Only formatting/layout adjustments are visible.
    Difference
    0.1%
    Check dated 2026-04-02T15:41:05.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content remains identical across both screenshots.
    Difference
    0.1%
    Check dated 2026-03-26T11:44:54.000Z thumbnail image

Stay in the know with updates to Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.